Correlation Between Biotechnology Fund and Us Vector

Can any of the company-specific risk be diversified away by investing in both Biotechnology Fund and Us Vector at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Fund and Us Vector into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Biotechnology Fund Class and Us Vector Equity, you can compare the effects of market volatilities on Biotechnology Fund and Us Vector and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Fund with a short position of Us Vector. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Fund and Us Vector.

Diversification Opportunities for Biotechnology Fund and Us Vector

0.38

Correlation Coefficient

Biotechnology Fund  Us Vector

Weak diversification

The 3 months correlation between Biotechnology and DFVEX is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Fund Class and Us Vector Equity in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Us Vector Equity and Biotechnology Fund is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Fund Class are associated (or correlated) with Us Vector. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Us Vector Equity has no effect on the direction of Biotechnology Fund i.e., Biotechnology Fund and Us Vector go up and down completely randomly.

Pair Corralation between Biotechnology Fund and Us Vector

Assuming the 90 days horizon Biotechnology Fund is expected to generate 1.01 times less return on investment than Us Vector. In addition to that, Biotechnology Fund is 1.53 times more volatile than Us Vector Equity. It trades about 0.09 of its total potential returns per unit of risk. Us Vector Equity is currently generating about 0.14 per unit of volatility. If you would invest  2,782  in Us Vector Equity on October 26, 2024 and sell it today you would earn a total of  58.00  from holding Us Vector Equity or generate 2.08% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Biotechnology Fund Class  vs.  Us Vector Equity

Biotechnology Fund Class

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Biotechnology Fund Class has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.

Us Vector Equity

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Us Vector Equity are ranked lower than 6 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong technical and fundamental indicators, Us Vector is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Biotechnology Fund and Us Vector

The main advantage of trading using opposite Biotechnology Fund and Us Vector positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Fund position performs unexpectedly, Us Vector can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Us Vector will offset losses from the drop in Us Vector's long position.

The idea behind Biotechnology Fund Class and Us Vector Equity pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.